Pulmonary arterial hypertension induced by dasatinib: positive reintroduction with nilotinib

被引:0
|
作者
Philibert, L. [1 ]
Cazorla, C. [1 ]
Peyriere, H. [1 ]
Mikulski, M. [1 ]
Guillemin, V. [1 ]
Pinzani-Harter, V. [1 ]
Hillaire-Buys, D. [1 ]
机构
[1] CRLC Val dAurelle, Montpellier, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
476
引用
收藏
页码:95 / 95
页数:1
相关论文
共 50 条
  • [1] Dasatinib-Induced Pulmonary Arterial Hypertension
    Orlikow, Evan
    Weatherald, Jason
    Hirani, Naushad
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (11) : 1604.e1 - 1604.e3
  • [2] Dasatinib-Induced Pulmonary Arterial Hypertension
    Zeb, Hassan
    El-Kersh, Karim
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E695 - E696
  • [3] Reversible Pulmonary Arterial Hypertension Induced by Dasatinib
    Lee, Hsiu-Chuan
    Huang, Chi-Cheng
    ACTA CARDIOLOGICA SINICA, 2022, 38 (05) : 635 - 638
  • [4] Dasatinib-induced pulmonary arterial hypertension
    Yurttas, Nurgul Ozgur
    Eskazan, Ahmet Emre
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (05) : 835 - 845
  • [5] DASATINIB-INDUCED PULMONARY ARTERIAL HYPERTENSION
    Zeb, Hassan
    El-Kersh, Karim
    CHEST, 2019, 156 (04) : 62A - 62A
  • [7] Dasatinib-Induced Pulmonary Arterial Hypertension: A Case Report
    Liu, Ru
    Tang, Yinjiang
    Fu, Ting
    Zhou, Jianli
    Ma, Lijiao
    Yuan, Jinqing
    Xu, Ou
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2021, 12 : 33 - 39
  • [9] Dasatinib (Sprycel) and pulmonary arterial hypertension
    不详
    AUSTRALIAN PRESCRIBER, 2012, 35 (02) : 68 - 68
  • [10] Dasatinib-induced pulmonary arterial hypertension - A rare late complication
    Ibrahim, Uroosa
    Saqib, Amina
    Dhar, Vidhya
    Odaimi, Marcel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 727 - 730